Giovanni Allevi Selected Research

Giovanni Allevi Research Topics

Disease

17	Breast Neoplasms (Breast Cancer) 03/2018 - 06/2002
14	Neoplasms (Cancer) 01/2021 - 06/2002
5	Hypoxia (Hypoxemia) 10/2017 - 08/2006
2	Triple Negative Breast Neoplasms 11/2017 - 10/2016
1	Carcinoma (Carcinomatosis) 01/2021
1	Primary Ovarian Insufficiency 11/2017
1	Residual Neoplasm 10/2010
1	Bone Resorption 01/2007
1	Neoplasm Metastasis (Metastasis) 01/2007

Drug/Important Bio-Agent (IBA)

7	Epirubicin (Ellence)FDA LinkGeneric 10/2017 - 06/2004
6	Tamoxifen FDA LinkGeneric 03/2018 - 08/2006
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2015 - 08/2006
5	Letrozole (Femara)FDA LinkGeneric 05/2015 - 08/2006
5	Estrogen ReceptorsIBA 05/2015 - 08/2006
4	AnthracyclinesIBA 03/2018 - 08/2006
4	Biomarkers (Surrogate Marker)IBA 10/2017 - 09/2006
4	Aromatase InhibitorsIBA 05/2015 - 05/2008
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011 - 08/2006
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2017 - 01/2009
3	Proteins (Proteins, Gene)FDA Link 10/2017 - 01/2007
3	Biological ProductsIBA 10/2016 - 01/2011
3	Carbonic Anhydrase IXIBA 02/2011 - 09/2006
2	Hormones (Hormone)IBA 03/2018 - 01/2009
2	TOR Serine-Threonine KinasesIBA 05/2015 - 01/2009
2	Estrogen Receptor alphaIBA 02/2009 - 01/2009
1	Phenobarbital (Luminal)FDA Link 03/2018
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 11/2017
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2017
1	olaparibIBA 10/2016
1	Everolimus FDA Link 05/2015
1	exemestane (Aromasin)FDA Link 05/2015
1	EnzymesIBA 02/2011
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 02/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	Caspase 3 (Caspase-3)IBA 01/2009
1	Mitogen-Activated Protein KinasesIBA 01/2009
1	ErbB Receptors (EGF Receptor)IBA 01/2009
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2008
1	Sirolimus (Rapamycin)FDA Link 05/2008
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2008
1	HGF activatorIBA 01/2007
1	Messenger RNA (mRNA)IBA 01/2007
1	Oxygen (Dioxygen)IBA 08/2006
1	AntibodiesIBA 06/2002

Therapy/Procedure

9	Therapeutics 03/2018 - 08/2006
3	Drug Therapy (Chemotherapy) 03/2018 - 06/2002
3	Aftercare (After-Treatment) 05/2015 - 08/2006
2	Neoadjuvant Therapy 03/2018 - 08/2006
1	Palliative Care (Palliative Therapy) 01/2021
1	Ureterostomy 01/2021
1	Immunomodulation 02/2009
1	Immunotherapy 02/2009